Cleared Traditional

K163250 - Longitudinal Brain Imaging (LoBI) appli...

K163250 is the FDA 510(k) clearance for Longitudinal Brain Imaging (LoBI) appli... by Philips Medical Systems Nederland B.V.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 174-day FDA review.

K163250 · Philips Medical Systems Nederland B.V. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2017
Decision
174d
Days
Class 2
Risk

K163250 is an FDA 510(k) clearance for the Longitudinal Brain Imaging (LoBI) application. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Medical Systems Nederland B.V. (Best Noord-Brabant, NL). The FDA issued a Cleared decision on May 11, 2017 after a review of 174 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Medical Systems Nederland B.V. devices

Submission Details

510(k) Number K163250 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2016
Decision Date May 11, 2017
Days to Decision 174 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d slower than avg
Panel avg: 107d · This submission: 174d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Qsite
Yoram Levy

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1091
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K163250.
EchoPAC Software Only, EchoPAC Plug-in
K170847 · GE Medical Systems Ultrasound and Primary Care Diagnostics · Jun 2017
syngo Application Software
K170747 · Siemens Medical Solutions USA, Inc. · Jun 2017
Vitrea Software Toshiba Package
K171222 · Toshibamedical Systems Corporation · Jun 2017
SurgiCase Viewer
K170419 · Materialise NV · May 2017
NuVasive NuvaLine Mobile App
K162647 · Nu Vasive, Incorporated · May 2017
syngo.CT View&GO
K170952 · Siemens Medical Solutions USA, Inc. · Apr 2017